全文获取类型
收费全文 | 4496篇 |
免费 | 327篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 110篇 |
儿科学 | 134篇 |
妇产科学 | 78篇 |
基础医学 | 596篇 |
口腔科学 | 100篇 |
临床医学 | 374篇 |
内科学 | 1051篇 |
皮肤病学 | 142篇 |
神经病学 | 326篇 |
特种医学 | 111篇 |
外科学 | 701篇 |
综合类 | 20篇 |
一般理论 | 1篇 |
预防医学 | 396篇 |
眼科学 | 80篇 |
药学 | 232篇 |
中国医学 | 9篇 |
肿瘤学 | 367篇 |
出版年
2023年 | 30篇 |
2022年 | 10篇 |
2021年 | 129篇 |
2020年 | 67篇 |
2019年 | 126篇 |
2018年 | 135篇 |
2017年 | 92篇 |
2016年 | 92篇 |
2015年 | 114篇 |
2014年 | 145篇 |
2013年 | 190篇 |
2012年 | 285篇 |
2011年 | 285篇 |
2010年 | 186篇 |
2009年 | 148篇 |
2008年 | 267篇 |
2007年 | 242篇 |
2006年 | 237篇 |
2005年 | 273篇 |
2004年 | 206篇 |
2003年 | 236篇 |
2002年 | 212篇 |
2001年 | 146篇 |
2000年 | 143篇 |
1999年 | 114篇 |
1998年 | 45篇 |
1997年 | 40篇 |
1996年 | 38篇 |
1995年 | 21篇 |
1994年 | 12篇 |
1993年 | 17篇 |
1992年 | 43篇 |
1991年 | 57篇 |
1990年 | 59篇 |
1989年 | 37篇 |
1988年 | 41篇 |
1987年 | 39篇 |
1986年 | 29篇 |
1985年 | 26篇 |
1984年 | 29篇 |
1983年 | 14篇 |
1981年 | 8篇 |
1979年 | 14篇 |
1978年 | 13篇 |
1977年 | 9篇 |
1976年 | 7篇 |
1975年 | 8篇 |
1973年 | 17篇 |
1972年 | 18篇 |
1968年 | 8篇 |
排序方式: 共有4828条查询结果,搜索用时 78 毫秒
1.
Jose M. Morales Jose Angel Martinez-Flores Manuel Serrano Maria José Castro Francisco Javier Alfaro Florencio García Miguel Angel Martínez Amado Andrés Esther González Manuel Praga Estela Paz-Artal Antonio Serrano 《Journal of the American Society of Nephrology : JASN》2015,26(3):735-745
In the current immunosuppressive therapy era, vessel thrombosis is the most common cause of early graft loss after renal transplantation. The prevalence of IgA anti–β2-glycoprotein I antibodies (IgA-aB2GPI-ab) in patients on dialysis is elevated (>30%), and these antibodies correlate with mortality and cardiovascular morbidity. To evaluate the effect of IgA-aB2GPI-ab in patients with transplants, we followed all patients transplanted from 2000 to 2002 in the Hospital 12 de Octubre prospectively for 10 years. Presence of IgA-aB2GPI-ab in pretransplant serum was examined retrospectively. Of 269 patients, 89 patients were positive for IgA-aB2GPI-ab (33%; group 1), and the remaining patients were negative (67%; group 2). Graft loss at 6 months post-transplant was significantly higher in group 1 (10 of 89 versus 3 of 180 patients in group 2; P=0.002). The most frequent cause of graft loss was thrombosis of the vessels, which was observed only in group 1 (8 of 10 versus 0 of 3 patients in group 2; P=0.04). Multivariate analysis showed that the presence of IgA-aB2GPI-ab was an independent risk factor for early graft loss (P=0.04) and delayed graft function (P=0.04). There were no significant differences regarding patient survival between the two groups. Graft survival was similar in both groups after 6 months. In conclusion, patients with pretransplant IgA-aB2GPI-ab have a high risk of early graft loss caused by thrombosis and a high risk of delayed graft function. Therefore, pretransplant IgA-aB2GPI-ab may have a detrimental effect on early clinical outcomes after renal transplantation. 相似文献
2.
C. M. Crceles J. M. Serrano P. Marín E. Escudero E. Fernndez‐Varn 《Transboundary and Emerging Diseases》2006,53(6):300-304
The pharmacokinetics (PK) of moxifloxacin in healthy white New Zealand rabbits was studied following intravenous (IV) and subcutaneous (SC) administration routes as well as a SC long‐acting poloxamer 407 gel formulation (SC‐P407). Moxifloxacin concentrations were determined by high‐performance liquid chromatography assay with fluorescence detection. Mean half‐life for IV, SC and SC‐P407 routes was 2.15, 5.41 and 11.09 h. Clearance value after IV dosing was 0.78 l/kg/h. After SC administration, the mean absolute bioavailability was 117% and the Cmax was 1.61 ± 0.49 mg/l. After SC‐P407 administration, the bioavailability was 44% and the Cmax 1.83 was ±0.62 mg/l. No adverse effects were observed in any of the rabbits following IV, SC and SC‐P407 administration of moxifloxacin. Minimal inhibitory concentrations of moxifloxacin against different strains of Staphylococcus aureus from different european countries were used to compute the main pharmacodynamic (PD) surrogate markers of efficacy. The high tolerability of this SC‐P407 formulation and the favourable PK behaviour such as the long half‐life, acceptable bioavailability and excellent PK–PD ratios achieved indicate that it is likely to be effective in rabbits. 相似文献
3.
Hazel B Breitz Richard E Wendt Michael S Stabin Sui Shen William D Erwin Joseph G Rajendran Janet F Eary Lawrence Durack Ebrahim Delpassand William Martin Ruby F Meredith 《Journal of nuclear medicine》2006,47(3):534-542
166Ho-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene-phosphonate (DOTMP) is a tetraphosphonate molecule radiolabeled with 166Ho that localizes to bone surfaces. This study evaluated pharmacokinetics and radiation-absorbed dose to all organs from this beta-emitting radiopharmaceutical. METHODS: After two 1.1-GBq administrations of 166Ho-DOTMP, data from whole-body counting using a gamma-camera or uptake probe were assessed for reproducibility of whole-body retention in 12 patients with multiple myeloma. The radiation-absorbed dose to normal organs was estimated using MIRD methodology, applying residence times and S values for 166Ho. Marrow dose was estimated from measured activity retained after 18 h. The activity to deliver a therapeutic dose of 25 Gy to the marrow was determined. Methods based on region-of-interest (ROI) and whole-body clearance were evaluated to estimate kidney activity, because the radiotracer is rapidly excreted in the urine. The dose to the surface of the bladder wall was estimated using a dynamic bladder model. RESULTS: In clinical practice, gamma-camera methods were more reliable than uptake probe-based methods for whole-body counting. The intrapatient variability of dose calculations was less than 10% between the 2 tracer studies. Skeletal uptake of 166Ho-DOTMP varied from 19% to 39% (mean, 28%). The activity of 166Ho prescribed for therapy ranged from 38 to 67 GBq (1,030-1,810 mCi). After high-dose therapy, the estimates of absorbed dose to the kidney varied from 1.6 to 4 Gy using the whole-body clearance-based method and from 8.3 to 17.3 Gy using the ROI-based method. Bladder dose ranged from 10 to 20 Gy, bone surface dose ranged from 39 to 57 Gy, and doses to other organs were less than 2 Gy for all patients. Repetitive administration had no impact on tracer biodistribution, pharmacokinetics, or organ dose. CONCLUSION: Pharmacokinetics analysis validated gamma-camera whole-body counting of 166Ho as an appropriate approach to assess clearance and to estimate radiation-absorbed dose to normal organs except the kidneys. Quantitative gamma-camera imaging is difficult and requires scatter subtraction because of the multiple energy emissions of 166Ho. Kidney dose estimates were approximately 5-fold higher when the ROI-based method was used rather than the clearance-based model, and neither appeared reliable. In future clinical trials with 166Ho-DOTMP, we recommend that dose estimation based on the methods described here be used for all organs except the kidneys. Assumptions for the kidney dose require further evaluation. 相似文献
4.
J I?igo A Arce E Rodríguez D García de Viedma E Palenque M J Ruiz Serrano L Cabello F Chaves 《The international journal of tuberculosis and lung disease》2006,10(5):550-553
SETTING: Tuberculosis (TB) cases reported from nine districts of Madrid, where the percentage of immigrant population varied from 1.9% in 1996 to 12.2% in 2003. OBJECTIVE: To describe the trends in TB incidence from 1994 to 2003. DESIGN: Observational study. RESULTS: Between 1994-1995 and 2002-2003, the TB rate decreased from 48.5 (95% CI 45.8-51.1) to 23.3 per 100000 population (95% CI 21.5-25.1) (P < 0.001). The percentage of TB cases co-infected with HIV decreased from 55.9% in 1994 to 14.3% in 2003 (P < 0.001), whereas TB cases in foreigners increased from 2.6% in 1994 to 33.7% in 2003 (P < 0.001). CONCLUSION: Although the TB rates showed a marked decrease in the study period, the increasing impact of immigration contributed to slowing down the trend. 相似文献
5.
6.
J. M. Bellón N. García-Honduvilla N. Serrano M. Rodríguez G. Pascual J. Buján 《Hernia》2005,9(4):338-343
The component of a composite prosthesis, which makes contact with the visceral peritoneum, can be reabsorbable or non-reabsorbable,
and laminar or reticular. This study was designed to determine whether the composition of this second, barrier component could
improve its behavior at this interface. Abdominal wall defects in rabbits were repaired using a polypropylene prosthesis (PP),
or the composites Sepramesh (PP+h) or Vicryl (PP+v). Fourteen days after surgery, the implants were evaluated by light and
scanning electron microscopy, and immunohistochemistry. Prosthetic areas occupied by adhesions (PP: 71.08±5.09, PP+h: 18.55±4.96,
P+v: 69.69±16.81%), neoperitoneal thickness (PP: 256.17±21.68, PP+h: 83.11±19.63, PP+v:213.72±35.90 μm) and macrophage counts
(PP: 8.73±1.16, PP+h: 27.33±4.13, PP+v: 31.24±3.08%) showed significant differences (P<0.05). The tested biomaterials induced an optimal recipient tissue infiltration. Least adhesion formation was observed on
the PP+h implants. This suggests that the second component, although reabsorbable, should be smooth in structure. 相似文献
7.
8.
J M Cortina J Martinell V Artiz J Fraile S Serrano G Rabago 《The Thoracic and cardiovascular surgeon》1987,35(4):209-214
The results of combined medical and surgical management of 66 patients with active prosthetic valve endocarditis (APVE) are analyzed. Between 1970 and 1985, 3510 patients were operative survivors of mitral, aortic or double mitral-aortic valve replacement. Cumulative follow-up was 15,640 patient-years (mean 4.4 years). The overall annual incidence of reoperation for APVE was 0.42 +/- 0.05% (0.34 +/- 0.08% for biological and 0.46 +/- 0.06% for mechanical prostheses, p = n.s.). Early APVE occurred in 21 patients and 45 patients had late APVE. Indications for surgery were heart failure in 92%, systemic emboli in 5% and persistent sepsis in 3% of patients. Overall operative mortality (less than 30 days) was 38% (25/66). (Early APVE 52% and late APVE 31%). Anatomical location, valve design and number of prostheses implanted did not correlate with a higher operative risk. Overall endocarditis-related mortality was 56% (37/66). Uni and multivariate stepwise logistic regression analysis identified: 1) date of surgery (p = 0.01), 2) renal failure (p = 0.03) and 3) early APVE (p = 0.03) as predictors of endocarditis-related death. Actuarial survival at 1, 5 and 10 postoperative years was 41 +/- 6%, 30 +/- 6% and 24 +/- 7% respectively. This study confirms the high lethality of APVE. However, with adequate and aggressive combined medical and surgical management, some patients can be saved. 相似文献
9.
10.
Carcinoma of the male breast: Analysis of prognosis compared with matched female patients 总被引:6,自引:0,他引:6
Dr. Patrick I. Borgen MD Ruby T. Senie PhD William M. P. McKinnon MD Paul Peter Rosen MD 《Annals of surgical oncology》1997,4(5):385-388
Background: Considerable debate exists concerning the prognosis of breast cancer in male patients compared with that in female patients.
Some studies have observed worse prognosis for men; others suggested the higher mortality rates were primarily due to delayed
diagnosis.
Methods: Survival time from diagnosis with invasive disease to death resulting from breast cancer of 58 men treated between 1973 and
1989 was compared with survival of 174 women treated between 1976 and 1978 who were matched by stage of disease and age at
diagnosis. All patients were treated by mastectomy and axillary dissection.
Results: Tumors were ⩽2 cm in 70% of cases and 55% were free of axillary metastases. The histology of the tumors differed significantly
by gender (p<0.05). Significantly more men had estrogen receptor-positive tumors (87%) than did women (55%, p<0.001). Survival
at 10 years was similar for male and female patients. Multivariate analysis controlling for tumor size, number of positive
axillary lymph nodes, age at diagnosis, histology, and receptor status indicated no significant difference in survival of
male compared with female patients.
Conclusions: These data conflict with the conventional wisdom that breast cancer in men carries a worse prognosis than the disease in
women. Although histology of the tumor and receptor status differed by gender, these factors did not have an impact on survival
in these paired patients. Our data indicate that breast carcinoma in males is not biologically more aggressive than in females.
Presented at the 49th Annual Cancer Symposium of The Society of Surgical Oncology, Atlanta, Georgia, March 21–24, 1996. 相似文献